The p-tau levels in CSF are elevated in patients with Alzheimer’s disease (AD) spectrum showing Aβ accumulation in the brain, which accelerates p-tau secretion from damaged neurons [15,20]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.